Immunotherapy: Neoadjuvant and/or adjuvant? Literature review
DOI 10.31917/2404337
N.A. Falaleeva, E.A. Bykova, L.Yu. Grivtsova, A.S. Belokhvostova, A.А. Danilenko, I.S. Pimonova, P.V. Shegai, S.A. Ivanov, A.D. Kaprin
Neoadjuvant endocrine therapy for breast cancer: state of the art
DOI 10.31917/2404395
А.А. Zavialov, A.I. Tyryshkin, S.E. Varlamova.
Efficacy of neoadjuvant endocrine therapy in HR-positive/HER2-negative breast cancer: A review
DOI 10.31917/2404406
N.K. Abduloeva, V.M. Moiseenko, F.V. Moiseenko, O.A. Skripko, M.V. Scriabin, R.A. Ryandjina
The significance of the dynamics of PET biomarkers in assessing the response to R-CHOP immunochemotherapy in patients with diffuse large B-cell lymphoma
DOI 10.31917/2404412
Y.N. Vinogradova, M.S. Tlostanova, A.A. Ivanova, M.I. Zelyanina, N.V. Ilyin
Effect of surgical risk factors on the short-term outcomes for rectal cancer surgery. Laparoscopic or robotic approach?
DOI 10.31917/2404420
M.E. Moiseev, D.V. Gladyshev, V.A. Vetoshkin, S.A. Kovalenko, R.A. Murashko, S.Z. Hondziya, V.Yu. Svitich, S.S. Gnedash
Local treatment options for colorectal cancer patients with lung metastases: a literature review
DOI 10.31917/2404430
T.S. Boldyreva, М.Е. Ivannikov, Y.S. Yesakov, V.K. Lyadov
Analysis of the work of the central chemotherapy drugs breeding department in the State Medical Institution «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological) named after N.P. Napalkov» 2014–2022
DOI 10.31917/2404439
V.M. Moiseenko, A.S. Zhabina, F.V. Moiseenko, N.M. Volkov, V.V. Yegorenkov, R.A. Ranzhina, N.K. Abduloeva